why choose us

First received: June 26, 2023

Clinical Trial: A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 2 Diabetes

Study Type: INTERVENTIONAL


Official Title: A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight: A Randomized Double-Blind, Placebo-Contr

Brief Summary: The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have obesity or overweight (J1I-MC-GZBK master protocol) including a subset of participants who have obstructive sleep apnea (OSA) (J1I-MC-GSA2).The study will last about 89 weeks and will include up to 24 visits.

Read more